MEVACOR

LOE ApproachingSM

lovastatin

Merck & Co.
NDAORALTABLETPriority Review
Approved
Aug 1987
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1

Clinical Trials (1)

NCT00302952Phase 2Terminated

Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis

Started Nov 2007
Company
M&
Merck & Co.
RAHWAY, NJ
662 open jobs
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers